News
CDNA
27.85
+2.65%
0.72
Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (CDNA) and Medtronic (MDT)
TipRanks · 21h ago
Weekly Report: what happened at CDNA last week (0615-0619)?
Weekly Report · 4d ago
CareDx Reaches Analyst Target Price
NASDAQ · 6d ago
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
NASDAQ · 6d ago
CareDx showcases precision medicine diagnostics at ATC 2026
TipRanks · 06/18 11:19
CareDx says study links early AlloSure elevation after kidney transplant to higher 3-year graft loss risk
PUBT · 06/18 11:07
CareDx to present transplant diagnostics data at American Transplant Congress
PUBT · 06/18 11:05
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
Barchart · 06/18 06:05
CareDx CEO John Walter Hanna Jr sells 17,683 shares worth $424,836
PUBT · 06/17 20:06
Analysts’ Top Healthcare Picks: Certara (CERT), CareDx (CDNA)
TipRanks · 06/17 13:40
CareDx announces second KOAR analysis published in JASN
TipRanks · 06/16 20:12
CareDx KOAR study in JASN links AlloSure dd-cfDNA elevations to higher kidney graft loss risk
PUBT · 06/16 20:05
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
Barchart · 06/16 15:05
CareDx Shareholders Back Directors, Auditor and Equity Plan
TipRanks · 06/15 21:43
CareDx CEO John Walter Hanna Jr disposes of 21,998 shares worth $528,472.92
PUBT · 06/15 21:07
Weekly Report: what happened at CDNA last week (0608-0612)?
Weekly Report · 06/15 09:19
CareDx CEO John Walter Hanna Jr disposes of 4,835 shares for $116,046.84
PUBT · 06/08 20:06
Weekly Report: what happened at CDNA last week (0601-0605)?
Weekly Report · 06/08 09:19
Baron Discovery Fund Q1 2026: Who Moved The Needle
Seeking Alpha · 06/08 05:35
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
NASDAQ · 06/07 10:03
More
Webull provides a variety of real-time CDNA stock news. You can receive the latest news about Caredx through multiple platforms. This information may help you make smarter investment decisions.
About CDNA
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.